Kano Therapeutics
14 posts
Kano Therapeutics
@kano_tx
Harnessing single-stranded DNA for precision genome editing.
Cambridge, MA Katılım Haziran 2022
25 Takip Edilen71 Takipçiler
Kano Therapeutics retweetledi
Bright Minds: The CEO of @kano_tx discusses circular single-stranded DNA, and life as a startup.
Full video: biotechtv.com/post/kano-ther…
English
Kano Therapeutics retweetledi
We’re incredibly excited to publish the inaugural edition of the Decoding Bio Snapshot. Several months in the making, it profiles 40 companies operating at the intersection of computation and biology, ranging from pre-seed to publicly traded.
snapshot.decodingbio.com
English
Kano Therapeutics is hiring a Senior Research Associate - Synthetic Biology, Gene Vector Design jobs.polymer.co/kano-therapeut…
English
Kano Therapeutics retweetledi
Downstream products capture the value of better, faster, cheaper DNA synthesis 🧬💉
I talk about the cost vs. quality conundrum and market dynamics that show where the value lies. 👇
shelbyann.substack.com/p/investing-in…
English
Kano and @Osmosesinc linked as #KanOsmoses to teach kids and their parents the importance of polymers.
#Cambridgesciencefestival #ssdna #polymers
English
1st hire - DONE. Fresh from his undergrad in Human Genetics at @tcddublin, Beaven joins us as RA. So excited to have him.
English
Kano Therapeutics retweetledi
Kano Therapeutics is also hiring 👀 Interested in DNA nanotechnology and synthetic biology? Check out their website to learn more about their growth: kanotherapeutics.com
#WhereBiotechBegins
Shazia Mir@ShaziaMir71
At our latest Chalk Talk @labcentral we hear from Co-Founder & CEO of Kano Therapeutics, Floris Englehardt-come hear all about their platform which seeks to revolutionize gene delivery and vaccine constructs for Pharmaceutical & Synthetic bio companies! @JohnTagliamonte
Cambridge, MA 🇺🇸 English
Kano Therapeutics retweetledi
Next up - Floris Engelhardt from Kano Therapeutics! Explaining the benefits of #singlestrandeddna and how Kano uses it for their platform tech
English
Kano Therapeutics retweetledi
Working in biomolecular design and honored as one of MIT's Innovative Women in Entrepreneurship 2020, Floris Engelhardt co-founded Kano Therapeutics, a biotechnology startup revolutionizing novel gene vectors through DNA nanotechnology and synthetic biology. #ScientistsOnAMission
English
Kano Therapeutics retweetledi
🏆 Congrats #ActivateFellows Aanindeeta Banerjee (ReSource Chemical, Cohort 2020) Cheri Ackerman (@ConcertoBio, Cohort 2020), & Floris Engelhardt
(Kano Therapeutics, Cohort 2021) on winning The Wave Summit's Emerging Women Founder Award: buff.ly/3cCQ8bP
@petribio
English
Kano Therapeutics retweetledi
Kano Therapeutics won the 2021 Sloan Healthcare Innovations Prize with its novel approach for producing single-stranded DNA (ssDNA).
news.mit.edu/2021/team-impr…
English
Kano Therapeutics retweetledi
Join us for the @LabCentral Golden Ticket event on Oct 22 and hear more about the innovation of our 3 finalists @Rubik Tx, @Glyphic Bio and Kano Therapeutics as well as what @Roche and @Genentech bring to the table in a long-term discovery collaboration.
LabCentral@LabCentral
Hear from @Roche and @Genentech on the power of partnerships at our upcoming Golden Ticket Pitch event. Teams will pitch their very best ideas and our sponsors will share insights on what makes the best collaborations. Register: labcentral.site/RocheGenentech
English